Lord, Abbett & Co. LLC Genfit S.A. Transaction History

Lord, Abbett & Co. LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$13.55 - $20.14 $2.84 Million - $4.22 Million	-209,479 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$14.92 - $19.94 $552,159 - $737,939	-37,008 Reduced 15.01%	209,479 $3.65 Million
Q2 2019 Aug 14, 2019	BUY	$19.74 - $25.65 $776,295 - $1.01 Million	39,326 Added 18.98%	246,487 $4.87 Million
Q1 2019 May 15, 2019	BUY	$22.17 - $24.0 $4.59 Million - $4.97 Million	207,161 New	207,161 $4.97 Million

76.8K

Ticker GNFT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 49,815,500
Market Cap $207M
Description
Genfit S.A., a biopharmaceutical company, discovers and develops drug candidates and diagnostic solutions for metabolic and liver-related diseases. The company's products include Elafibranor, which is in Phase 3 clinical trial to treat patients with primary biliary cholangitis. It also engages in the development of NIS4 technology for the diagno...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.